IL17A and neoplasm: Consistent with our prior findings, these data further confirmed that Vγ1 γδ T cells were the major IL-17A-producing γδ T cells in tumours, and the anti-tumour effect of BTNL2 blockade was dependent on the regulation of Vγ1 γδT17 cells.